查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1169166

臨床前資產市場：按服務分類（生物分析和 DMPK 試驗、毒理學試驗、化合物管理、模型類型、最終用戶、地區）- 規模、份額、前景、機會分析2022-2030

Preclinical Assets Market, by Service ( Bioanalysis and DMPK studies, Toxicology Testing, compound management, by Model type, by End user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

臨床前資產包括生物分析和 DMPK（藥物代謝和藥代動力學）研究（加上體外和體內分析、GLP 和非 GLP（良好實驗室規範）毒理學研究、化合物管理流程研發（研發）、定制合成、不對稱合成和其他（放大、cGMP、安全藥理學）等。臨床前資產有兩類：患者來源的類器官（PDO）模型和患者來源的異種移植模型。是的。

市場動態

主要市場參與者在臨床前試驗中啟動的服務數量不斷增加，預計將在預測期內推動全球臨床前資產市場的增長。 例如，2020 年 7 月，化妝品公司 Skinobs 宣布新推出臨床前測試平台 skinobs，這是一個獨立的工具，可提供 360 度全方位的體內功效測試視野。 該平台允許用戶根據各種標準識別和選擇測試方法，例如：

  • 測試類別：包括分析測試、內容物-空氣相互作用、生態毒性和生物降解性測試、安全測試、UV（紫外線）測試等。
  • 聲明：包括抗衰老、抗污染等。
  • 測試支持：包括細胞培養、3D 皮膚模型等。

同樣，2021 年 12 月，軟件公司 Sirona Medical 在 2021 年北美放射學會 (RSNA) 年會上宣布，其雲原生放射學技術將優化新型 AI（人工智能）應用程序在臨床中的使用。宣布推出學術操作系統（RadOS）。 該平台基於技術和人工智能的結合，將有助於增強醫生在臨床環境中的智能。

這項研究的主要特點

  • 本報告以 2021 年為基準年，詳細分析了 2022 年至 2030 年預測期內的全球臨床前資產市場、市場規模（百萬美元）和復合年增長率（CAGR（%））分析。
  • 本文闡述了各個細分市場的潛在創收機會，並描述了該市場具有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素和推動因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 根據公司概況、財務業績、產品組合、地域分佈、分銷戰略、主要發展和戰略等參數對全球臨床前資產市場的主要參與者進行了概況分析。
  • 本研究涵蓋的主要公司包括 Eurofins Scientific、ICON plc、WuXi AppTec、Viroclinics Xplore、Medpace, Inc.、Charles River Laboratories.、Pharmatest Services、PPD Inc.、SGS SA (SGS)、Intertek Group plc、Labcorp Drug Development, Laboratory Corporation of America, Inc.、Crown Bioscience、Comparative Biosciences, Inc.、TCG Lifesciences Private Limited.、Shanghai Medicilon Inc.、Domainex、Absorption Systems、AmplifyBio 和 IQVIA
  • 這份報告中的見解將使企業營銷人員和高管能夠就未來的產品發布、政府舉措、技術升級、市場擴張和營銷策略做出明智的決策。這似乎是有可能的。
  • 《全球臨床前資產市場》報告面向該行業的各種利益相關者，包括投資者、產品製造商、分銷商、供應商、研究和諮詢公司、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球臨床前資產市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第2章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按服務分類
    • 按型號類型劃分的市場概況
    • 市場概況：按最終用戶分類
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

  • 市場動態
    • 司機
    • 約束因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要發展狀況
  • 技術進步
  • 監管狀況
  • 害蟲分析

第 4 章全球臨床前資產市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 總體影響
  • COVID-19 對市場的影響

第 5 章全球臨床前資產市場：按服務分類，2017-2030

  • 2022 年和 2030 年市場份額分析 (%)
  • 2017-2030 年同比增長率分析
  • 生物分析和 DMPK 研究
  • 體外
  • 體內
  • 毒理學測試
  • GLP
  • 非 GLP
  • 複合管理
  • 工藝研發
  • 自定義合成
  • 不對稱合成
  • 其他（放大、cGMP）
  • 安全藥理學
  • 其他（化學等）

第 6 章全球臨床前資產市場：按模型類型分類，2017-2030

  • 患者來源的類器官 (PDO) 模型
  • 患者來源的異種移植模型

第 7 章全球臨床前資產市場：按最終用戶分類，2017-2030

  • 生物製藥公司
  • 政府機構
  • 其他（學術/研究機構）

第 8 章全球臨床前資產市場：按地區劃分，2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中非
  • 南非

第9章競爭格局

  • 熱圖分析
  • 公司簡介
    • Eurofins Scientific
    • ICON plc
    • WuXi AppTec
    • Viroclinics Xplore
    • Medpace, Inc.
    • Charles River Laboratories.
    • Pharmatest Services
    • PPD Inc.
    • SGS SA（SGS）
    • Intertek Group plc
    • Labcorp Drug Development
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
    • Comparative Biosciences, Inc.
    • TCG Lifesciences Private Limited.
    • Shanghai Medicilon Inc.
    • Domainex
    • Absorption Systems
    • AmplifyBio
    • IQVIA

第10章 章節

  • 參考文獻
  • 調查手法介紹
  • 關於出版社
簡介目錄
Product Code: CMI5326

Preclinical assets consist of various types of services such as Bioanalysis and DMPK (Drug Metabolism and pharmacokinetics) studies, which are further sub segmented into in vitro and in vivo analysis, toxicology testing, which are based on GLP and non GLP (Good Laboratory Practices), compound management process R&D (Research and development), custom synthesis, asymmetric synthesis, and others (Scale-up, cGMP (current good manufacturing practices), safety pharmacology. Preclinical assets have two types of models, patient derived organoid (PDO) model and patient derived xenograft model.

Market Dynamics

Increasing number of service launch in preclinical testing by the key market players is expected to drive growth of the global preclinical assets market during the forecast period. For instance, in July 2020, Skinobs, a cosmetic company, announced the launch of a new preclinical testing platform skinobs, an independent tool which provides a 360-degree vision of in vivo efficacy testing. This platform enables users to identify and select the testing methods depending on various criteria such as

  • Test Category: which include analytical tests, content-contenair interaction, ecotoxicity and biodegradability tests, safety tests, UV (Ultra Violet ) tests, etc.
  • Claim: which include anti-ageing, anti-pollution, etc.
  • Test support: which include cell cultures, 3D skin models, etc.

Similarly, in December 2021, Sirona Medical, a software company, announced the launch of its cloud-native radiology operating system (RadOS) optimizing the use of novel AI (Artificial Intelligence) applications in clinical practice at the 2021 Annual Meeting for Radiological Society of North America (RSNA). The platform was based on the combination of technology and artificial intelligence, which would help augment the intelligence of the physician in clinical practices.

Key features of the study:

  • This report provides an in-depth analysis of the global preclinical assets market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global preclinical assets market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Eurofins Scientific, ICON plc, WuXi AppTec, Viroclinics Xplore, Medpace, Inc., Charles River Laboratories., Pharmatest Services, PPD Inc., SGS SA (SGS), Intertek Group plc, Labcorp Drug Development, Laboratory Corporation of America, Inc., Crown Bioscience, Comparative Biosciences, Inc., TCG Lifesciences Private Limited., Shanghai Medicilon Inc., Domainex, Absorption Systems, AmplifyBio, and IQVIA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global preclinical assets market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical assets market

Detailed Segmentation:

  • Global Preclinical Assets Market, By Service:
    • Bioanalysis and DMPK studies
      • In vitro
      • In-vivo
    • Toxicology Testing
      • GLP
      • Non-GLP
    • Compound Management
      • Process R&D
      • Custom Synthesis
      • Asymmetric Synthesis
      • Others (Scale-up, cGMP, etc.)
    • Safety Pharmacology
    • Others (Chemistry, etc.)
  • Global Preclinical Assets Market, By Model Type:
    • Patient Derived Organoid (PDO) Model
    • Patient derived xenograft model
  • Global Preclinical Assets Market, By End User:
    • Biopharmaceutical Companies
    • Government Institutes
    • Others (Academic and Research institutes)
  • Global Preclinical Assets Market, By Region:
    • North America
      • By Country
    • US
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Eurofins Scientific*
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • ICON plc
    • WuXi AppTec
    • Viroclinics Xplore
    • Medpace, Inc.
    • Charles River Laboratories.
    • Pharmatest Services
    • PPD Inc.
    • SGS SA (SGS)
    • Intertek Group plc
    • Labcorp Drug Development
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
    • Comparative Biosciences, Inc.
    • TCG Lifesciences Private Limited.
    • Shanghai Medicilon Inc.
    • Domainex
    • Absorption Systems
    • AmplifyBio
    • IQVIA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service
    • Market Snapshot, By Model Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Regulatory Landscape
  • PEST Analysis

4. Global Preclinical Assets Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Preclinical Assets Market, By Service, 2017 - 2030, (US$ Million)

  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017- 2030
    • Segment Trends
  • Bioanalysis and DMPK studies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • In vitro
  • In-vivo
  • Toxicology Testing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • GLP
  • Non-GLP
  • Compound Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Process R&D
  • Custom Synthesis
  • Asymmetric Synthesis
  • Others (Scale-up and cGMP)
  • Safety Pharmacology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others (Chemistry, etc.)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Preclinical Assets Market, By Model Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Patient Derived Organoid (PDO) Model
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Patient derived xenograft model
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Preclinical Assets Market, By End User, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Government Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others (Academic and Research institutes)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Preclinical Assets Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Eurofins Scientific
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • ICON plc
    • WuXi AppTec
    • Viroclinics Xplore
    • Medpace, Inc.
    • Charles River Laboratories.
    • Pharmatest Services
    • PPD Inc.
    • SGS SA (SGS)
    • Intertek Group plc
    • Labcorp Drug Development
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
    • Comparative Biosciences, Inc.
    • TCG Lifesciences Private Limited.
    • Shanghai Medicilon Inc.
    • Domainex
    • Absorption Systems
    • AmplifyBio
    • IQVIA
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us